These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7978066)
1. Spiradenocarcinoma: a clinicopathologic and immunohistochemical study of three cases. Biernat W; Wozniak L Am J Dermatopathol; 1994 Aug; 16(4):377-82. PubMed ID: 7978066 [TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of eccrine spiradenoma. Cooper PH; Frierson HF; Morrison AG Arch Dermatol; 1985 Nov; 121(11):1445-8. PubMed ID: 2996443 [TBL] [Abstract][Full Text] [Related]
3. Malignant eccrine spiradenoma: a case report with pulmonary metastasis. Chou SC; Lin SL; Tseng HH Pathol Int; 2004 Mar; 54(3):208-12. PubMed ID: 14989745 [TBL] [Abstract][Full Text] [Related]
4. Malignant eccrine spiradenoma: a case report and review of the literature. Ishikawa M; Nakanishi Y; Yamazaki N; Yamamoto A Dermatol Surg; 2001 Jan; 27(1):67-70. PubMed ID: 11231249 [TBL] [Abstract][Full Text] [Related]
5. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280 [TBL] [Abstract][Full Text] [Related]
6. [Carcinosarcoma arising in eccrine spiradenoma. A morphologic and immunohistochemical study]. Huerre M; Bonnet D; Mc Carthy SW; de Saint Maur PP Ann Pathol; 1994; 14(3):168-73. PubMed ID: 8037805 [TBL] [Abstract][Full Text] [Related]
8. Spiradenocylindrocarcinoma: a malignant hybrid tumor. Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677 [TBL] [Abstract][Full Text] [Related]
9. Spiradenoma associated with apocrine adenoma component. Michal M Pathol Res Pract; 1996 Nov; 192(11):1135-9; discussion 1140-1. PubMed ID: 9122033 [TBL] [Abstract][Full Text] [Related]
10. Eccrine spiradenoma: a report of malignant transformation. Engel CJ; Meads GE; Joseph NG; Stavraky W Can J Surg; 1991 Oct; 34(5):477-80. PubMed ID: 1655199 [TBL] [Abstract][Full Text] [Related]
11. [Vascular eccrine giant spiradenoma--a case report with histology and immunohistology of a rare variant of benign sweat gland tumors]. Hey A; Grouls V; Röckelein G Z Hautkr; 1988 May; 63(5):444-7. PubMed ID: 2841813 [TBL] [Abstract][Full Text] [Related]
12. Spiradenocarcinoma of the breast arising in a long-standing spiradenoma. Ribeiro-Silva A; Shaletich C; Careta RS; Kazava DK; Siqueira MC; Ponton F Ann Diagn Pathol; 2004 Jun; 8(3):162-6. PubMed ID: 15185264 [TBL] [Abstract][Full Text] [Related]
13. Malignant mixed tumor ex eccrine spiradenoma: an unusual pattern of malignant dedifferentiation. Lara JF; Nadeem MA; Asaadi M Ann Diagn Pathol; 2001 Jun; 5(3):155-61. PubMed ID: 11436169 [TBL] [Abstract][Full Text] [Related]
14. Histological findings and pathologic diagnosis of spiradenocarcinoma: A case series and review of the literature. Huang A; Vyas NS; Mercer SE; Phelps RG J Cutan Pathol; 2019 Apr; 46(4):243-250. PubMed ID: 30588645 [TBL] [Abstract][Full Text] [Related]
15. Spiradenoma with marked adenomyoepitheliomatous features. Kacerovska D; Kazakov DV; Kutzner H; Michal M Am J Dermatopathol; 2010 Oct; 32(7):744-6. PubMed ID: 20859082 [No Abstract] [Full Text] [Related]
16. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Granter SR; Seeger K; Calonje E; Busam K; McKee PH Am J Dermatopathol; 2000 Apr; 22(2):97-103. PubMed ID: 10770427 [TBL] [Abstract][Full Text] [Related]
17. [Case of clear cell hidradenoma with mucinous metaplasia in the forehead--immunohistochemical analysis of the mucin]. Ishida M; Kojima F; Kushima R; Kakutani A; Okabe H Rinsho Byori; 2006 Aug; 54(8):781-4. PubMed ID: 16989395 [TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex spiradenoma/cylindroma confirmed by immunohistochemical and molecular loss-of-heterozygosity profiling. Jukic DM; Drogowski LM; Davie JR Am J Dermatopathol; 2009 Oct; 31(7):702-8. PubMed ID: 19684510 [TBL] [Abstract][Full Text] [Related]
19. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Biernat W; Kordek R; Woźniak L Histopathology; 1995 May; 26(5):439-43. PubMed ID: 7657312 [TBL] [Abstract][Full Text] [Related]
20. Carcinosarcoma arising in eccrine spiradenoma of the breast. Report of a case and review of the literature. Saboorian MH; Kenny M; Ashfaq R; Albores-Saavedra J Arch Pathol Lab Med; 1996 May; 120(5):501-4. PubMed ID: 8639057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]